Clinical Trial Update: Sputum Matrix Metalloproteinases (MMP) mRNA and Montelukast [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Montelukast in asthma, with measurements of sputum MMP mRNA. The University of East Anglia study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: University of East Anglia | Conditions: Asthma | Phase 2 | Status: COMPLETED